According to GlobalData, SHOCKWAVE M5+ is one of 97 product lines sold in the US pta balloon catheters market; these product lines are sold by 17 different manufacturers. The price of the SHOCKWAVE M5+ device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.

Smarter leaders trust GlobalData

The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.

In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Shockwave Medical apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.

Shockwave Medical overview

Shockwave Medical Inc (Shockwave) is a medical device provider for the treatment of atherosclerotic cardiovascular disease. The company specializes in reshaping cardiovascular interventional therapy with intravascular lithotripsy (IVL) technology. It provides products such as M5 catheter, M5+ catheter, and S4 catheter for the treatment of peripheral artery disease and C2 catheter for the treatment of coronary artery diseases. Its treatment portfolio includes Coronary Artery Disease and atherectomy. The company provides treating peripheral artery disease which occurs primarily in the legs and vessels throughout the body. It operates in the US, the UK, Japan, Germany and France. Shockwave is headquartered in Santa Clara, California, the US.

For a complete picture of SHOCKWAVE M5+, PTA Balloon Catheters pricing in the US, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.